Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Gender Health Policy topic
No spam. Unsubscribe anytime.
Heated testimony as committee considers bill to extend legal recourse and insurance coverage for minors harmed by gender-affirming care
Summary
House Bill 682 would extend the time and insurance coverage available to people who received gender-affirming medical care as minors and later sought care to reverse or remediate those interventions, prompting lengthy, often emotional testimony at a Senate Judiciary Committee hearing.
The Senate Judiciary Committee heard extensive testimony on House Bill 682, a measure that would create extended legal remedies and require insurance reciprocity for people who received gender-affirming medical care as minors and later seek medical care to reverse or mitigate those interventions.
Sponsor opening: the bill's sponsor framed HB 682 as a response to individuals who later report harm from gender-affirming interventions received as minors. The sponsor told the committee the bill would not affect adults and said it was intended to allow injured detransitioners a realistic time window to bring claims and to ensure insurers cover necessary care to address those harms.
Proponents: A mix of medical professionals, detransitioners and advocacy groups testified in favor. Pediatrician Brian Starr said he believes hormone and surgical treatments for minors carry long-term, and in some cases irreversible, harms and argued that some minors cannot give informed consent. Detransitioners testifying included Elle Palmer and Prisha Mosley, who described receiving hormones or being encouraged toward surgeries as adolescents and later experiencing medical complications and difficulty finding care. Palmer said she sought legal help but was told the two-year statute of limitations had run.
Several speakers urged a longer limitations period than the bill's text then provided; some asked for an extended deadline up to age 25. Proponents also urged insurers to cover detransition-related care.
Opponents: The ACLU of Montana, Planned Parenthood Advocates of Montana, the Montana Hospital Association and healthcare providers testified against the bill. Henry Seaton of the ACLU warned the bill would deter clinicians from practicing in Montana and said decisions between clinicians and transgender patients should not be legislated. Quinn Leighton of Planned Parenthood explained that gender-affirming care is rarely immediate and typically involves multi-disciplinary assessment.
The Montana Hospital Association warned HB 682 would hinder providers and asked the committee to consider the bill's potential effect on access to standard-of-care medical services. Several opponents said the bill singles out one type of care for different legal treatment and warned of constitutional and practical consequences.
Committee questions covered: the availability of gender-affirming care in Montana for minors and adults, the number of procedures and prescriptions cited by witnesses, whether detransition care (for example, laser hair removal or stopping hormones) is covered by insurance, and whether suicide prevention evidence supports or contradicts access to transition care. Witnesses disagreed on the evidence.
No vote was taken. The sponsor urged a favorable report; opponents urged rejection. The debate highlighted deep disagreements about clinical evidence, consent capacity for minors, and how the law should treat procedures that some adults later report they regret.
